Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Dynamic Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: International

Challenger Global Fonds - Challenger Global Four Fonds

+ Add to Watchlist

CHAGLFO:LX

12.13 EUR 0.11 0.90%

As of 00:59:30 ET on 04/24/2015.

Snapshot for Challenger Global Fonds - Challenger Global Four Fonds (CHAGLFO)

Year To Date: +22.28% 3-Month: +13.79% 3-Year: +7.30% 52-Week Range: 8.91 - 12.36
1-Month: +2.54% 1-Year: +26.49% 5-Year: +3.16% Beta vs LUXXX: 0.68

Mutual Fund Chart for CHAGLFO

No chart data available.
  • CHAGLFO:LX 12.13
  • 1M
  • 1Y
Interactive CHAGLFO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CHAGLFO

Challenger Global Four Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is capital appreciation. The Fund invests primarily in equities and equity-related securities issued in OECD member countries. The Fund may also invest in securities issued in emerging markets worldwide with the exception of Eastern Europe.

Inception Date: 12-04-2002 Telephone: 352-42-44-911
Managers: -
Web Site: www.warburg-fonds.com

Fundamentals for CHAGLFO

NAV (on 2015-04-24) 12.13
Assets (M) (on 2015-04-24) 3.66
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment -

Dividends for CHAGLFO

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for CHAGLFO

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.35
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 3.15

Top Fund Holdings for CHAGLFO

Filing Date: 01/30/2015
Name Position Value % of Total
Gilead Sciences Inc 2,600 236,886 7.046%
Jazz Pharmaceuticals PLC 1,500 227,948 6.780%
Coloplast A/S 3,100 218,427 6.497%
Actavis plc 850 205,125 6.101%
Celgene Corp 1,800 192,145 5.715%
Constellation Software Inc/Can 670 162,210 4.825%
Constellation Brands Inc 1,640 161,900 4.816%
DexCom Inc 3,000 161,618 4.807%
Eurofins Scientific SE 680 156,094 4.643%
MasterCard Inc 2,000 143,743 4.276%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil